Mangoceuticals Inc. (MGRX)
2.60
0.02 (0.78%)
At close: Jan 15, 2025, 10:56 AM
Company Description
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform.
It offers erectile dysfunction products under the Mango brand name.
The company sells its products through online website mangorx.com.
Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas.
Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
Mangoceuticals Inc.
| Country | United States |
| IPO Date | Mar 21, 2023 |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Employees | 3 |
| CEO | Jacob D. Cohen |
Contact Details
Address: 15110 North Dallas Parkway Dallas, Texas United States | |
| Website | https://www.mangorx.com |
Stock Details
| Ticker Symbol | MGRX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001938046 |
| CUSIP Number | 56270V106 |
| ISIN Number | US56270V1061 |
| Employer ID | 87-3841292 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Jacob D. Cohen | Co-Founder, Chief Executive Officer & Chairman |
| Amanda Elizabeth Hammer | Chief Operating Officer |
| Eugene M. Johnston | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 08, 2025 | 8-K | Current Report |
| Dec 26, 2024 | 8-K | Current Report |
| Dec 19, 2024 | 8-K | Current Report |
| Dec 06, 2024 | 8-K | Current Report |
| Nov 14, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | 4 | Filing |
| Nov 12, 2024 | 8-K | Current Report |
| Oct 31, 2024 | 8-K | Current Report |
| Oct 25, 2024 | 8-K | Current Report |
| Oct 22, 2024 | 8-K | Current Report |